BNP Paribas Asset Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,269,179
| Closed | -$378K | – | 875 |
|
|
2023
Q2 | $378K | Buy |
1,269,179
+564,255
| +80% | +$168K | ﹤0.01% | 799 |
|
|
2023
Q1 | $305K | Sell |
704,924
-250,546
| -26% | -$108K | ﹤0.01% | 838 |
|
|
2022
Q4 | $1.13M | Sell |
955,470
-145,748
| -13% | -$172K | ﹤0.01% | 762 |
|
|
2022
Q3 | $2.56M | Buy |
1,101,218
+975,746
| +778% | +$2.26M | 0.01% | 651 |
|
|
2022
Q2 | $277K | Buy |
125,472
+19,363
| +18% | +$42.7K | ﹤0.01% | 894 |
|
|
2022
Q1 | $1.02M | Buy |
+106,109
| New | +$1.02M | ﹤0.01% | 731 |
|